BioVie Inc.BIVINASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-200.00%
↑ 83% above average
Average (39q)
-1182.93%
Historical baseline
Range
High:165.33%
Low:-37727.27%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -200.00% |
| Q2 2025 | 165.33% |
| Q1 2025 | 67.39% |
| Q4 2024 | 34.29% |
| Q3 2024 | 13.58% |
| Q2 2024 | 59.50% |
| Q1 2024 | -809.09% |
| Q4 2023 | 24.66% |
| Q3 2023 | 88.37% |
| Q2 2023 | -483.72% |
| Q1 2023 | 14.00% |
| Q4 2022 | -31.58% |
| Q3 2022 | 88.27% |
| Q2 2022 | -15.71% |
| Q1 2022 | -1172.73% |
| Q4 2021 | 4.35% |
| Q3 2021 | 99.72% |
| Q2 2021 | -37727.27% |
| Q1 2021 | 90.00% |
| Q4 2020 | 97.16% |
| Q3 2020 | -110.37% |
| Q2 2020 | -5162.86% |
| Q1 2020 | -105.43% |
| Q4 2019 | 125.49% |
| Q3 2019 | -1932.13% |
| Q2 2019 | 26.76% |
| Q1 2019 | -70.00% |
| Q4 2018 | -1.52% |
| Q3 2018 | 73.20% |
| Q2 2018 | 41.20% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | -107.30% |
| Q2 2017 | -147.13% |
| Q1 2017 | 52.25% |
| Q4 2016 | -1.39% |
| Q3 2016 | -30.23% |
| Q2 2016 | -366.27% |
| Q1 2016 | -16.90% |
| Q4 2015 | 8.97% |